Skip to main content
S 2076 117th Congress Senate Health Administrative law and regulatory procedures Advisory bodies Appropriations Congressional oversight Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug therapy Executive agency funding and structure Government information and archives Government studies and investigations Health programs administration and funding Indian social and development programs Infectious and parasitic diseases Manufacturing Medicaid Medicare Military medicine Minority health Prescription drugs

PASTEUR Act of 2021

Introduced: June 16, 2021 Introduced by: Bennet, Michael F. Democratic · Colorado See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 16, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 16, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

The Pioneering Antimicrobial Subscriptions To End Up surging Resistance Act of 2021 or the PASTEUR Act of 2021

This bill authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs, provides $11 billion in appropriations for activities under the bill, and contains other related provisions.

A manufacturer of a Food and Drug Administration-approved antimicrobial drug may apply to HHS to have the drug designated as a critical-need antimicrobial, and HHS may enter into a subscription contract for such a critical-need antimicrobial. The bill imposes certain requirements related to such contracts, including a mechanism to lower payments under the contract in certain instances to limit the manufacturer's revenue from the drug.

Furthermore, HHS and the Centers for Disease Control and Prevention (CDC) shall award grants to support efforts to encourage the appropriate use of antimicrobial drugs and efforts to combat antimicrobial resistance. The CDC shall also track and assess data relating to antibacterial resistance and human antibiotic use and make such data publicly available.

HHS shall also establish a Committee on Critical Need Antimicrobials. The committee shall develop a list of prioritized infections for which new antimicrobial drug development is needed, among other duties.

Within six years of the bill's enactment, the Government Accountability Office shall report to Congress a study on the bill's effectiveness in developing priority antimicrobial drugs.

What's happening now June 16, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 2
  • HR 6000 Related bill Cures 2.0 Act
  • HR 3932 Identical bill PASTEUR Act of 2021
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 11

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • SHIONOGI INC.
    for SHIONOGI INC. · New Jersey · 2nd Quarter (Apr 1 - June 30) 2026
  • MERCK & CO, INC.
    for MERCK & CO INC · New Jersey · 2nd Quarter (Apr 1 - June 30) 2026
  • MERCK & CO, INC.
    for MERCK & CO INC · New Jersey · 1st Quarter (Jan 1 - Mar 31) 2026
  • SHIONOGI INC.
    for SHIONOGI INC. · New Jersey · 1st Quarter (Jan 1 - Mar 31) 2026
  • SHIONOGI INC.
    for SHIONOGI INC. · New Jersey · 4th Quarter (Oct 1 - Dec 31) 2025
  • MERCK & CO, INC.
    for MERCK & CO INC · New Jersey · 4th Quarter (Oct 1 - Dec 31) 2025
See all 11 filings →
 Cosponsors 5
All 5 Democratic 2 Republican 3
R
Rounds, Mike
South Dakota · Dec 15, 2022
 D
Hickenlooper, John W.
Colorado · Dec 14, 2022
 R
Collins, Susan M.
Maine · Apr 4, 2022
 D
Gillibrand, Kirsten E.
New York · Apr 4, 2022
 R
Young, Todd
Indiana · Jun 16, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2076: PASTEUR Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-2076/
MLA
"S. 2076: PASTEUR Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2076/.
Bluebook (legal)
S. 2076, 117th Cong. (2026), https://openamerica.io/bill/117-S-2076/.
Markdown link
[S. 2076: PASTEUR Act of 2021](https://openamerica.io/bill/117-S-2076/)
Report a problem